On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
Reminder - On Wednesday June 6, 2018 at 10:00AM PST, we will be hosting a webinar regarding the chan...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...